Santos David A Insider Trades

Insider Trading History

Track insider trading activity for Santos David A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $1.9M 62,870 shares
Last Trade
Feb 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$691k 19,430 shares
$35.55
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $1.31M 43,440 shares
Last Trade
Feb 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$123k 3,546 shares
$34.62
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $1.42M 46,986 shares
Last Trade
Feb 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$206k 5,718 shares
$36.01
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $224k 7,394 shares
Last Trade
Sep 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$276k 7,394 shares
$37.30
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $237k 7,850 shares
Last Trade
Mar 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$310k 14,725 shares
$21.03
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $1.56M 51,704 shares
Last Trade
Feb 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$39.4k 1,796 shares
$21.93
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $1.62M 53,500 shares
Last Trade
Feb 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$44.5k 2,125 shares
$20.92
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $1.68M 55,625 shares
Last Trade
Jan 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$333k 14,788 shares
$22.49
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $242k 8,000 shares
Last Trade
Nov 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$209k 8,000 shares
$26.09
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $2.42M 80,000 shares
Last Trade
Feb 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.46M 158,500 shares
$15.50
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $10.6M 349,093 shares
Last Trade
Feb 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$104k 8,918 shares
$11.70
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $10.8M 358,011 shares
Last Trade
Feb 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$63.9k 5,601 shares
$11.40
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $11M 363,612 shares
Last Trade
Jan 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.99M 157,000 shares
$12.70
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $4.37M 144,612 shares
Last Trade
Feb 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$95.4k 5,388 shares
$17.70
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director, Evp, Chief Commercial Officer
Holding Value $4.84M 160,000 shares
Last Trade
Jan 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.93M 210,000 shares
$18.70
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Director, Evp, Chief Commercial Officer
Holding Value $1.51M 50,000 shares
Last Trade
Dec 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$655k 50,000 shares
$13.10
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $3.03M 100,000 shares
Last Trade
Jan 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.42M 100,000 shares
$24.20
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $4.16M 137,500 shares
Last Trade
Jan 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.87M 137,500 shares
$35.40
$30.25
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
Evp, Chief Commercial Officer
Holding Value $7.56M 250,000 shares
Last Trade
Aug 19, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.3M 250,000 shares
$25.20
$30.25

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up